Search

Premise / BY: William A. Falk, MD, FCFPC, FRCGP December 2002
... disability per year were greater in the low-income group (17.8 days) compared with 11.0 in the medium-income group, 9.6 ...
Clinical Articles / BY: Jiri Frohlich, MD, FRCPC May 2002
... contribute together to recurrent coronary events. [17]  Increased levels of D-dimer, if present, together with ...
Clinical Articles / BY: Suzanne Montemuro, MD, CCFP October 2001
... 65 compared with when they were in their 20s (10%), 30s (17%), or 40s (16%). They also reported an interest in healthy ... creams are not recommended for endometrial protection. [ 17,18]  These preparations contain variable amounts of ... was found to be useful for controlling hot flushes. [ 17,18] When using estrogen for symptom relief, titrate the ...
Clinical Articles / BY: A.J. Pollard MBBS, MRCPCH, PhD, DIC January/February 2001
... Y, and W135 meningococci is available in North America.[ 17 ] This vaccine is used in the control of outbreaks, for ...
Letters / BY: R.A. Bernat, MD July / August 2001
... care unit run by family physicians. It currently has 17 beds. Plus we have a strong presence in the long-term care ...
Clinical Articles / BY: T.A. Hurwitz, MBChB, MRCP, FRCPC May 2001
... feed off each other, making both worse over time. [17]  Management depends upon correctly diagnosing the ...
Clinical Articles / BY: Timothy C. Rowe, MBBS, FRCSC, FRCOG November 2001
... should continue until there is no withdrawal bleeding. [ 17] Selective estrogen receptor modulators Selective estrogen ... 5 mg $22.64 Prometrium Micronized progesterone 100 mg $17.07 Provera Medroxyprogesterone acetate 2.5 mg 5 mg 10 mg ... acetate 5 µg (estrogen)  1.0 mg (progestin) $22.17 PremPlus conjugated equine estrogens and ...
Clinical Articles / BY: Marilyn L. Malone, MD, FRCPC January/February 2001
... zanamivir dose was delivered under these circumstances.[ 17 ] To date no studies have shown neuraminidase inhibitors ...
Clinical Articles / BY: Janet Henderson, MB, BCh September 2001
... also be constitutively expressed in the gastric mucosa [17]  and it should be noted that COX-2 inhibitors commonly ... for inhalation. The bioavailability is between 4% and 17% as systemic absorption is quite low. [2,6]  Zanamivir is ... use in patients with influenza. Pharmacoeconom 2000;17:187-195.  PubMed Abstract Rizatriptan  (Maxalt—Merck ...
Clinical Articles / BY: Christopher R. Honey, MD, DPhil, FRCS May 2001
... Parkinson Disease Rating Scale) total motor scores (17% to 46% decrease from baseline) and on-period drug-induced ... to 92% of patients and less than 80% in his own series. [17]  Complications specific to thalamotomy include ... in 117 patients (80 PD, 20 essential tremor, and 17 other) with more than 85% left with little or no tremor in ...